🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Pei Hui

Pei Hui

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability”.

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

Cancer(2021)10.1002/cncr.34025

N/A

2.4DataRank · unranked

80 citations

Dana M. Roque, Eric R. Siegel, Natália Buza, Pei Hui, Elena Bonazzoli +28 more

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)

Annals of Oncology(2021)10.1016/j.annonc.2021.04.013

N/A

1.9DataRank · unranked

50 citations

Dana M. Roque, Eric R. Siegel, Natália Buza, Pei Hui, Elena Bonazzoli +28 more

A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste

medRxiv(2022)10.1101/2022.01.28.22270035

N/A

1.4DataRank · unranked

27 citations

Anne Spichler-Moffarah, Ole S. Søgaard, Denise Esserman, James Dziura, Lisa Danzig +19 more

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

Gynecologic Oncology Reports(2020)10.1016/j.gore.2020.100554

N/A

0DataRank · unranked

8 citations

Natália Buza, Pei Hui, Stefania Bellone, Burak Zeybek, Elena Ratner +4 more

SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.08.459464

N/A

0DataRank · unranked

4 citations

Therese A. Yario, Sylvia S. White, Jianhui Wang, Walter N. Moss, Pei Hui +3 more

Lineage abundance estimation for SARS-CoV-2 in wastewater using transcriptome quantification techniques

Genome biology(2022)10.1186/s13059-022-02805-9

N/A

0DataRank · unranked

55 citations

Alessandro Zulli, Isabel M. Ott, Ioanna Nika, Mart J. van der Lugt, Mary E. Petrone +48 more

Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.014

N/A

0DataRank · unranked

30 citations

Stefania Bellone, Diego Manavella, Levent Mutlu, Blair McNamara, Tobias M.P. Hartwich +17 more

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0126

N/A

0DataRank · unranked

8 citations

Diego Manavella, Stefania Bellone, Blair McNamara, Justin Harold, Dennis Mauricio +17 more

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.009

N/A

0DataRank · unranked

4 citations

Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias M.P. Hartwich +24 more

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2321898121

N/A

0DataRank · unranked

18 citations

Kyungjo Jeong, Mari K. Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman +33 more

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2

Clinical & Experimental Metastasis(2024)10.1007/s10585-024-10297-z

N/A

0DataRank · unranked

9 citations

Blair McNamara, Stefania Bellone, Diego Manavella, Cem Demirkiran, Michelle Greenman +16 more

SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer

Cancers(2025)10.3390/cancers17020244

N/A

0DataRank · unranked

5 citations

Fangfang Bi, Zhiping Ge, Miranda Mansolf, Tobias M.P. Hartwich, Viktoriia Kolesnyk +8 more

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.00118

N/A

0DataRank · unranked

64 citations

Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra +17 more

Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma

JCI Insight(2025)10.1172/jci.insight.187073

N/A

0DataRank · unranked

1 citations

Trey E Gilpin, Apoorva T. Patil, Emily Chiu, R. W. R. Baker, Peng Liu +18 more

Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations

American Journal of Clinical Pathology(2020)10.1093/ajcp/aqaa188

N/A

0DataRank · unranked

13 citations

W. Glenn McCluggage, Teresa M. Darragh, Wenxin Zheng, Jennifer M. Roberts, Kay J. Park +5 more

Molecular and clinicopathologic characterization of intravenous leiomyomatosis

Modern Pathology(2020)10.1038/s41379-020-0546-8

N/A

0DataRank · unranked

42 citations

Hongyan Chai, Gang Peng, Anna G. McDonald, Michele De Nictolis, Eugenia García‐Fernández +7 more